Drug Profile
Analgecine - Vanway Pharmaceutical
Alternative Names: AGC; AnalgecineLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Vanway
- Class Analgesics; Anti-ischaemics; Antiallergics; Biological factors; Hypnosedatives; Neuroprotectants
- Mechanism of Action Bradykinin receptor antagonists; Serotonin receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Back pain; Neuralgia
- Discontinued Neuropathic pain
Most Recent Events
- 29 Sep 2021 Discontinued - Phase-III for Neuropathic pain in China (Infusion)
- 10 Dec 2018 No development reported - Phase-III for Neuropathic pain in China (Infusion)
- 01 Jul 2014 Vanway completes a phase III trial in Back pain in China (NCT02168010)